Rheonix Inc., a developer of fully automated molecular testing solutions and Life technologies Corp, a leader in life sciences tools and diagnostic markets, just signed a joint agreement. The technology developed by Rheonix for the molecular diagnostics market includes the Rheonix CARD®, a disposable cartridge that can run multiple samples simultaneously without user intervention.
Once a sample is placed on the Rheonix CARD, the automated platform runs with no user intervention through the process of sample extraction, DNA purification, amplification, and detection. The technology eliminates the need for multiple pieces of existing equipment and helps to make the testing process quicker, more efficient, less expensive, and less likely to result in human errors.
The instrument and consummate cartridges are components of a molecular detection system specifically designed for the food testing market that will enable laboratories to detect disease-causing organisms in a fully automated and efficient manner.
Rheonix will supply the molecular testing technology to Life Technologies to market, sell, and distribute. “This partnership is a great example of combining the innovation of Rheonix with the molecular testing menu and hardware expertise of Life Technologies,” said Tony Eisenhut, President of Rheonix. The new platform is targeted for initial introduction in 2014.
For more information, go to www.rheonix.com.